Get the Stockscreener App
1.73
2.37%
0.04
After Hours:
1.73
Ikena Oncology Inc Stock (IKNA) Forecast
The Ikena Oncology Inc (IKNA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.1615, representing a +429.57% increase from the current price of $1.73. The highest analyst price target is $10.95, and the lowest is $7.368.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IKNA Price Target
Average 10.49
(+506.44% Upside)
Is Ikena Oncology Inc (IKNA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.17 | Neutral |
| STOCH(9,6) | 46.51 | Neutral |
| STOCHRSI(14) | 67.76 | Neutral |
| MACD(12,26) | -0.000092 | Sell |
| ADX(14) | 34.76 | Buy |
| William %R | -46.15 | Neutral |
| CCI(14) | 17.61 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.7025
Buy
|
1.7106
Buy
|
| MA20 |
1.7143
Buy
|
1.711
Buy
|
| MA50 |
1.7093
Buy
|
1.7065
Buy
|
| MA100 |
1.6991
Buy
|
1.7005
Buy
|
| MA200 |
1.5891
Buy
|
1.9202
Sell
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, IKNA could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on IKNA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.17 indicates that IKNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 46.51 indicates that IKNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 67.76 indicates that IKNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.76 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 17.61 indicates that IKNA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term IKNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Ikena Oncology Inc financial reports and earnings history, Ikena Oncology Inc (IKNA) stock could reach $18.88 by 2030, $75.84 by 2040 and $151.85 by 2050. See the projected annual prices until 2050 of the Ikena Oncology Inc stock below:
- Ikena Oncology Inc (IKNA) is expected to reach an average price of $80.55 in 2035, with a high prediction of $84.08 and a low estimate of $84.06. This indicates an $4,556% rise from the last recorded price of $1.73.
- Ikena Oncology Inc (IKNA) stock is projected to chart a bullish course in 2040, with an average price target of $73.16, representing an $4,129% surge from its current level. The forecast ranges from a conservative $74.40 to a sky-high $75.84.
- Our analysts predict Ikena Oncology Inc (IKNA) to jump 1,624% by 2045, soaring from $29.32 to an average price of $29.82, potentially reaching $30.06. While $29.32 is the low estimate, the potential upside is significant.
- Ikena Oncology Inc (IKNA) stock is expected to climb by 2050, reaching an average of $152.29, a $8,703% jump from its current level. However, a wide range of estimates exists, with high and low targets of $151.85 and $152.81, respectively, highlighting the market's uncertainty.
Ikena Oncology Inc Stock (IKNA) Year by Year Forecast
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2025
Ikena Oncology Inc Stock (IKNA) is expected to reach an average price of $10.49 in 2025, with a high prediction of $13.61 and a low estimate of $7.368. This indicates an +506.44% rise from the last recorded price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.4091 | $7.368 | $10.95 | +270.47% |
| February, 2025 | $7.8132 | $8.5532 | $6.2111 | +351.63% |
| March, 2025 | $9.1873 | $8.2942 | $7.7373 | +431.06% |
| April, 2025 | $10.14 | $9.8783 | $10.15 | +486.27% |
| May, 2025 | $13.08 | $12.11 | $12.92 | +655.87% |
| June, 2025 | $12.65 | $12.66 | $11.70 | +631.25% |
| July, 2025 | $14.18 | $11.74 | $12.37 | +719.41% |
| August, 2025 | $14.14 | $14.25 | $13.61 | +717.34% |
| September, 2025 | $13.33 | $13.60 | $13.20 | +670.75% |
| October, 2025 | $10.96 | $11.41 | $12.04 | +533.48% |
| November, 2025 | $10.47 | $10.68 | $10.75 | +505.39% |
| December, 2025 | $9.7484 | $10.42 | $10.45 | +463.49% |
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2026
The predicted value for Ikena Oncology Inc (IKNA) in 2026 is set at an average of $6.6227. Estimates vary from a peak of $11.19 to a trough of $2.0557, indicating an +282.82% surge from the present price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.46 | $10.90 | $10.59 | +562.57% |
| February, 2026 | $11.14 | $11.31 | $10.97 | +543.74% |
| March, 2026 | $10.97 | $11.22 | $11.19 | +534.15% |
| April, 2026 | $9.7859 | $10.38 | $10.49 | +465.66% |
| May, 2026 | $8.00 | $8.8404 | $9.4969 | +362.43% |
| June, 2026 | $8.7941 | $7.5521 | $7.381 | +408.33% |
| July, 2026 | $6.3192 | $6.6942 | $7.1251 | +265.27% |
| August, 2026 | $6.1334 | $6.8503 | $6.4823 | +254.53% |
| September, 2026 | $2.5785 | $2.9185 | $5.0344 | +49.05% |
| October, 2026 | $2.2526 | $2.7126 | $2.5206 | +30.21% |
| November, 2026 | $1.9067 | $2.0557 | $1.7436 | +10.22% |
| December, 2026 | $2.6219 | $2.1888 | $2.3719 | +51.55% |
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Ikena Oncology Inc (IKNA) is $15.69, with a high forecast of $31.29 and a low forecast of $0.0941. This indicates an +807.00% increase from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.226 | $2.7129 | $2.6949 | +28.67% |
| February, 2027 | $2.2101 | $2.588 | $2.0901 | +27.75% |
| March, 2027 | $2.5852 | $2.2221 | $1.9032 | +49.44% |
| April, 2027 | $3.9493 | $1.5783 | $1.6273 | +128.29% |
| May, 2027 | $3.3534 | $3.4334 | $3.4204 | +93.84% |
| June, 2027 | $2.3386 | $2.3576 | $2.7445 | +35.18% |
| July, 2027 | $2.2627 | $2.2196 | $2.2227 | +30.79% |
| August, 2027 | $1.7168 | $1.7668 | $2.0437 | -0.76% |
| September, 2027 | $0.872 | $0.912 | $1.2882 | -49.60% |
| October, 2027 | $0.4661 | $0.5761 | $0.723 | -73.06% |
| November, 2027 | $25.65 | $0.0941 | $20.21 | +1,383% |
| December, 2027 | $28.04 | $30.44 | $31.29 | +1,521% |
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2028
In 2028, Ikena Oncology Inc (IKNA) is projected to reach an average price of $33.26, with a high projection of $37.35 and a low estimate of $29.18. This indicates an +1,823% rise from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $33.40 | $29.48 | $31.99 | +1,831% |
| February, 2028 | $35.92 | $36.43 | $35.31 | +1,976% |
| March, 2028 | $38.00 | $36.72 | $35.38 | +2,096% |
| April, 2028 | $35.92 | $37.43 | $37.35 | +1,976% |
| May, 2028 | $33.43 | $34.13 | $34.20 | +1,832% |
| June, 2028 | $32.24 | $33.35 | $32.50 | +1,764% |
| July, 2028 | $30.54 | $33.39 | $33.18 | +1,665% |
| August, 2028 | $30.78 | $29.18 | $27.60 | +1,679% |
| September, 2028 | $29.13 | $29.27 | $26.84 | +1,584% |
| October, 2028 | $31.12 | $30.15 | $29.33 | +1,699% |
| November, 2028 | $32.62 | $30.45 | $31.12 | +1,785% |
| December, 2028 | $30.05 | $32.29 | $32.36 | +1,637% |
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2029
The 2029 price forecast for Ikena Oncology Inc Stock (IKNA) is $25.27 on average, with a high prediction of $31.19 and a low estimate of $19.35. This represents an +1,361% increase from the previous price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $29.68 | $30.08 | $30.98 | +1,615% |
| February, 2029 | $31.82 | $30.85 | $30.90 | +1,739% |
| March, 2029 | $30.58 | $31.22 | $31.19 | +1,668% |
| April, 2029 | $28.90 | $29.18 | $29.82 | +1,571% |
| May, 2029 | $26.88 | $27.07 | $28.57 | +1,454% |
| June, 2029 | $25.99 | $26.08 | $25.79 | +1,402% |
| July, 2029 | $25.66 | $25.42 | $25.72 | +1,383% |
| August, 2029 | $25.52 | $25.56 | $25.31 | +1,375% |
| September, 2029 | $25.10 | $25.19 | $24.85 | +1,351% |
| October, 2029 | $22.94 | $23.63 | $24.66 | +1,226% |
| November, 2029 | $21.54 | $22.26 | $22.38 | +1,145% |
| December, 2029 | $19.34 | $19.35 | $21.04 | +1,018% |
Ikena Oncology Inc Stock (IKNA) Price Forecast for 2030
Ikena Oncology Inc Stock (IKNA) is expected to reach an average price of $13.00 in 2030, with a high forecast of $18.88 and a low forecast of $7.1266. This signifies an +651.53% surge from the last price of $1.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.20 | $18.66 | $18.88 | +952.28% |
| February, 2030 | $17.44 | $17.52 | $17.32 | +908.24% |
| March, 2030 | $15.15 | $15.59 | $16.89 | +775.77% |
| April, 2030 | $12.53 | $12.50 | $14.09 | +624.22% |
| May, 2030 | $10.49 | $11.22 | $11.82 | +506.32% |
| June, 2030 | $10.27 | $10.38 | $10.05 | +493.50% |
| July, 2030 | $10.69 | $10.35 | $10.14 | +517.79% |
| August, 2030 | $9.0561 | $9.5261 | $10.05 | +423.47% |
| September, 2030 | $8.4343 | $8.6043 | $8.7782 | +387.53% |
| October, 2030 | $7.3446 | $7.9146 | $8.1463 | +324.54% |
| November, 2030 | $8.6828 | $7.1266 | $8.6907 | +401.90% |
| December, 2030 | $7.181 | $7.351 | $8.3048 | +315.09% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):